Pharmesis International Ltd

BFK

Company Profile

  • Business description

    Pharmesis International Ltd is an investment holding company. The company manufactures pharmaceutical products in the form of tablets, granules, pills, and other forms. Its operating segments are Western drugs, which are chemically formulated drugs and are marketed under the Kinna brand; TCM-formulated drugs, which refer to Traditional Chinese Medicine and are marketed under the Longlife brand; and Distribution, which refers to agency products and internally manufactured products which are marketed through the distribution arm. The company derives revenue from the sale of medicines to domestic customers in China.

  • Contact

    5 Kallang Sector
    No. 03-02
    Singapore349279
    SGP

    T: +65 68460766

    https://www.pharmesis.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

Stocks News & Analysis

stocks

2 picks in an undervalued ASX sector

Investors may be too pessimistic about this industry.
stocks

AMD and OpenAI partnership

What does another huge AI deal mean for investors?
stocks

Undervalued ASX founder-led companies

Can this strategy pick the winners?

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,220.8035.80-0.39%
CAC 407,974.853.070.04%
DAX 4024,385.787.490.03%
Dow JONES (US)46,602.9891.99-0.20%
FTSE 1009,483.584.440.05%
HKSE26,957.77183.15-0.67%
NASDAQ22,788.36153.30-0.67%
Nikkei 22548,096.55145.670.30%
NZX 50 Index13,537.586.290.05%
S&P 5006,714.5925.69-0.38%
S&P/ASX 2008,927.9030.50-0.34%
SSE Composite Index3,882.7820.250.52%

Market Movers